The FDA says that they are aiming to reclassify drugs containing hydrocodone, an opioid painkiller that, inmany cases,can potentially lead to addiction.
This new classification means that a patient prescribed these drugs will be limited in the number of refills they can receive before following-up with their doctor. It also means that patients must have a written prescription when they go tothe pharmacy; no doctor phone-in prescriptions will be accepted.
Manydoctorsoppose this proposed change, citing that it would cause unnecessary difficulties to the patients, especially tothe elderly. However, the FDA argues that the addiction to these painkillers has resulted in too many deaths.
On its website, the FDA released a statement that it has become "increasingly concerned about the abuse and misuse of opioid products, which have sadly reached epidemic proportions in certain parts of the United States."